|
Age, years
|
64.4 ± 9.6
|
65.0 ± 10.1
|
0.8857
|
|
Male, n (%)
|
6 (50.0)
|
6 (50.0)
|
1.0000
|
|
Hemodialysis duration, years
|
26.3 ± 7.9
|
20.8 ± 6.7
|
0.0785
|
|
Observation period, months
|
61.9 ± 16.3
|
58.0 ± 12.2
|
0.5120
|
|
Diabetes mellitus, n (%)
|
2 (16.7)
|
1 (8.3)
|
0.8913
|
|
Dry weight, kg
|
51.3 ± 9.6
|
47.13
|
0.2595
|
|
Body mass index, kg/m2
|
20.5 ± 3.6
|
19.4 ± 2.5
|
0.7984
|
|
Cardiothoracic rate, %
|
50.7 ± 4.9
|
51.7 ± 4.8
|
0.3092
|
|
Systolic blood pressure before dialysis, mmHg
|
137.6 ± 25.9
|
140.4 ± 14.1
|
0.7551
|
|
Diastolic blood pressure before dialysis, mmHg
|
74.8 ± 14.9
|
75.1 ± 10.3
|
0.9497
|
|
BMIPP summed score at first BMIPP SPECT
|
6 (3.0–17.5)
|
6 (2.0–9.5)
|
0.3645
|
|
Hemoglobin, g/dl
|
10.8 ± 0.5
|
10.6 ± 0.5
|
0.4212
|
|
Urea nitrogen, mg/dl
|
57.8 ± 7.12
|
58.7 ± 7.5
|
0.7738
|
|
Creatinine, mg/dl
|
9.0 ± 2.3
|
10.1 ± 2.7
|
0.3126
|
|
Calcium mg/dl
|
8.7 ± 0.45
|
8.6 ± 0.6
|
0.7557
|
|
Inorganic phosphorus, mg/dl
|
5.3 ± 0.8
|
5.5 ± 0.8
|
0.4139
|
|
Albumin, g/dl
|
3.7 ± 0.3
|
3.6 ± 0.44
|
0.6687
|
|
β2-microglobulin, mg/l
|
23.0 ± 4.6
|
29.2 ± 5.2
|
0.0056
|
|
C-reactive protein, mg/dl
|
0.42 (0.14–0.98)
|
0.58 (0.16–1.1)
|
0.9310
|
|
Parathyroid hormone-intact, pg/ml
|
88.7 (29.5–166.3)
|
62.8 (16.3–139.5)
|
0.3708
|
|
Dialysis mode (hemodialysis/hemodiafiltration), n
|
12/0
|
10/2
|
0.4783
|
|
Dialysis time, h
|
4.2 ± 0.4
|
4.6 ± 0.6
|
0.0538
|
|
Single pool Kt/V urea
|
1.93 ± 0.27
|
2.01 ± 0.32
|
0.5016
|
|
Normalized protein catabolism rate, g/kg/day
|
0.86 ± 0.11
|
0.89 ± 0.09
|
0.4212
|
|
Geriatric Nutritional Risk Index
|
92.9 ± 4.2
|
90.9 ± 9.5
|
0.5092
|
|
Creatinine generation rate, %
|
93.5 ± 20.8
|
109.0 ± 26.5
|
0.1234
|
|
Medications
|
|
α1 blockers, n (%)
|
1 (8.3)
|
2 (16.7)
|
0.5371
|
|
β1 blockers, n (%)
|
1 (8.3)
|
4 (33.3)
|
0.1316
|
|
Calcium channel blockers, n (%)
|
6 (50.0)
|
7 (58.3)
|
0.6820
|
|
Nitrates, n (%)
|
0 (0.0)
|
0 (0.0)
|
–
|
|
Angiotensin-converting enzyme inhibitors, n (%)
|
1 (8.3)
|
2 (16.7)
|
0.5371
|
|
Angiotensin II receptor blockers, n (%)
|
2 (16.7)
|
2 (16.7)
|
1.0000
|
|
Antiplatelet drugs, n (%)
|
5 (41.7)
|
3 (25.0)
|
0.3865
|
|
Stains, n (%)
|
1 (8.3)
|
1 (8.3)
|
1.0000
|
